PARKINSON DISEASE (Disorder) Clinical Trials in Dresden
2 recruitingDresden, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 3
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
PARKINSON DISEASE (Disorder)
University Hospital Tuebingen150 enrolled3 locationsNCT07151378
Recruiting
Phase 1Phase 2
Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
SafetyPARKINSON DISEASE (Disorder)Apathy
Integrative Research Laboratories AB75 enrolled13 locationsNCT07461220